Health Research Authority’s Guidance on the use of the UK template Confidentiality Disclosure Agreements: model Confidentiality Disclosure Agreement (mCDA) and model Master Confidentiality Disclosure Agreement (mMCDA)(Catapult’s regulatory round-up – May 2024)

A study-specific CDA template and its associated guidance have been produced by a UK-wide partnership to help make the early sharing of information, for feasibility and site set-up purposes, clearer and more efficient in line with the UK Vision for Clinical Research Delivery. The recommended template aims to reduce negotiation time with sites, provide assurances to both parties that their rights and responsibilities are appropriate and facilitate compliance by sites with contract terms, replacing the inconsistency of terms to which NHS organisations are currently subject.

Please find further information, including access to the latest version of agreement (April 2024) here.

Published on the 5th of June in Catapult’s regulatory round-up for May 2024.